Gastroesophageal reflux disease
ICD-10 K21 · ICD-11 DA22

GERD with Persistent Heartburn and Regurgitation After an 8-Week PPI Trial

When classic gastroesophageal reflux disease symptoms — heartburn and regurgitation — continue despite completing an initial 8-week course of once-daily proton pump inhibitor (PPI) therapy, a structured next-line strategy is warranted. This protocol addresses that specific clinical situation.

Previous Treatment — Target Not Reached

The initial line combined lifestyle modifications (including weight management, avoiding meals close to bedtime, tobacco avoidance, trigger food avoidance, and head-of-bed elevation for nighttime symptoms) with an 8-week empiric once-daily PPI trial taken 30 to 60 minutes before a meal. The goal was relief of classic GERD symptoms — heartburn and regurgitation. This protocol applies when that goal was not achieved.

Next-Step Approach (Overview)

The recommended next step centres on optimisation of PPI therapy — examining how and when the medication is taken and whether changes to the dosing pattern or the specific agent used may improve outcomes. Patients with persistent nocturnal symptoms are addressed separately within this approach.

Instant Access to Structured Evidence-Based Regimens